A Randomized, Placebo-controlled, Double-blind Trial of Intravenous Immunoglobulin for Women With Unexplained Secondary Recurrent Miscarriage
Phase of Trial: Phase III
Latest Information Update: 10 Nov 2014
At a glance
- Drugs Immune globulin (Primary) ; Albumin human
- Indications Spontaneous abortion
- Focus Therapeutic Use
- 05 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Dec 2012 Planned End Date changed from 1 Nov 2010 to 1 May 2014.